EichorEICHOR
Location: Sylmar Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Sylmar

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Olive View UCLA Medical Center · Novartis Pharmaceuticals · NCT05755386Aveir AR Coverage With Evidence Development (CED) Study
Phase N/A · Abbott · Abbott Medical Devices · NCT06100770Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
NA · Site 04 · BioStem Technologies · NCT06811909Starting Technology in At Risk Type 1 Diabetes Study
NA · Olive View-UCLA Medical Center · University of California, Los Angeles · NCT06453928A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · Olive View UCLA Medical Center /ID# 259092 · AbbVie · NCT06345339Reducing Blood Pressure in Patients With High Cardiovascular Risk
NA · Olive View Medical Center · University of Southern California · NCT05937685Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Phase 2 · Olive View UCLA Medical Center · Novartis Pharmaceuticals · NCT05268289Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
Phase N/A · Olive View - UCLA Medical Center · LifeNet Health · NCT05880537DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Tre
Phase 3 · Research Site · AstraZeneca · NCT06989112Telehealth vs In-Person Evaluation of Addiction Treatment After Visiting the Emergency Department
NA · Olive View - UCLA Medical Center Emegency Department · University of California, Davis · NCT06961058Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
Phase 2 · Olive View UCLA Education and Research Center · University of California, Los Angeles · NCT05304065AVEIR DR Coverage With Evidence Development (CED) Study
Phase N/A · Abbott · Abbott Medical Devices · NCT05932602Aveir DR Real-World Evidence Post-Approval Study
Phase N/A · Abbott · Abbott Medical Devices · NCT05935007Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Phase N/A · Clinical Trial Site · Alexion Pharmaceuticals, Inc. · NCT04202341A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
Phase 2 · Olive View UCLA Educ and Res Ins · Novartis Pharmaceuticals · NCT06632600Aveir VR Coverage With Evidence Development Post-Approval Study
Phase N/A · Abbott · Abbott Medical Devices · NCT05336877Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Pro
Phase 2 · Olive View-University of California Los Angeles Medical Cent · University of Washington · NCT06526299
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.